Expanding HPV and hepatitis B vaccination in Nigerian communities
US-Nigerian Cancer Control Center for Research on Implementation Science Excellence (C3-RISE)
This project partners with Nigerian communities to use locally designed approaches to boost HPV and hepatitis B vaccinations so fewer people develop cancer in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11177743 on NIH RePORTER |
What this research studies
If you live in Nigeria, this center will work with local communities, health workers, and leaders to find practical ways to bring HPV and hepatitis B vaccines closer to people where they live. The team will use participatory methods like crowdsourced ideas and hands-on apprenticeships to design and refine those approaches. They will pilot these strategies in community settings and build local research and implementation skills so programs can be sustained. U.S. universities and the Nigerian Institute of Medical Research will support training, testing, and sharing what works across regions.
Who could benefit from this research
Good fit: Ideal participants are Nigerian community members, adolescents (for HPV), infants or children (for HBV), community health workers, and local programs involved in vaccination delivery.
Not a fit: People living outside Nigeria or those already diagnosed with HPV- or HBV-related cancers are unlikely to benefit directly from the vaccine scale-up activities.
Why it matters
Potential benefit: If successful, more people—especially adolescents and infants—could receive HPV and HBV vaccines, which would reduce future cancer risk in Nigeria.
How similar studies have performed: HPV and HBV vaccines are proven to prevent cancers and community-engagement approaches have improved vaccine uptake elsewhere, but this specific participatory, Nigeria-focused implementation center is a newer, more comprehensive effort.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Iwelunmor, Juliet — Washington University
- Study coordinator: Iwelunmor, Juliet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.